Who
Kumud Kalia
Chief Information Officer
Company insider
Files Form 4 as: Chief Information Officer, Guardant Health.
In numbers
- Trades disclosed
- 264
- Buys
- 3
- Sells
- 16
- Bought
- $293K
- Sold
- $13.0M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 17 Aug 2022
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,607 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,084 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,995 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,360 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code F | $536K3,067 at $174.75 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,607 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,084 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,995 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,360 at $0.00 | filing |
| 11 Sep 2026filed 14 Sep 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $632K4,000 at $158.05 | filing |
| 11 Sep 2026filed 14 Sep 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $632K4,000 at $158.05 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,607 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,084 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,994 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,607 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,084 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,994 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,361 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,361 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code F | $524K3,066 at $170.77 | filing |
News
Guardant Health (NASDAQ:GH) Stock Purchase Reported by Rep. Jonathan L. JacksonGH · dailypolitical.com · 22 Oct 2026Contrasting BrightSpring Health Services (NASDAQ:BTSG) and Guardant Health (NASDAQ:GH)GH · tickerreport.com · 21 Oct 2026Guardant Health (GH) Wins a New Breast Cancer Role. Can Its Growth Justify the Price?GH · insidermonkey.com · 20 Oct 2026
0 headlines in the last 90 days name Kumud Kalia; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.